Flagship Pioneering

News

Flagship's AI-focused Generate Biomedicines files IPO

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100m for phase 3 trials of its twice-yearly asthma drug.

News

Scientific 'superintelligence' firm Lila launches with $200m

Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.

News

Mirai Bio launches with plan to help genetic med developers

Flagship Pioneering's latest biotech launch, Mirai Bio, aims to help genetic medicine developers find the best way to get their drugs to patients.

News

AI firm Generate signs $1bn discovery deal with Novartis

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis.

News

GSK joins Flagship's flotilla of pharma partners

Flagship Pioneering has signed yet another strategic-level deal with a big pharma group, with GSK the latest to tap into its network of biotech companies in an alliance that could be worth

News

Noubar Afeyan, founder and chief executive of Flagship Pioneering

Flagship closes $3.6bn biotech fund, with a focus on AI

Venture capital group Flagship Pioneering has raised $2.6 billion to support the development of around 25 startups operating in human health, sustainability, and artificial intelligence, wi

Flagship's AI-focused Generate Biomedicines files IPO

Scientific 'superintelligence' firm Lila launches with $200m

Mirai Bio launches with plan to help genetic med developers

AI firm Generate signs $1bn discovery deal with Novartis

GSK joins Flagship's flotilla of pharma partners

Flagship closes $3.6bn biotech fund, with a focus on AI

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Flagship Pioneering

Editor's Picks